Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: Expert Opin Ther Pat. 2019 Jun 16;29(7):555–578. doi: 10.1080/13543776.2019.1630379

Table 6.

Examples of condensed dihydropyrimidone derivatives developed by Boehringer Ingelheim GmbH.

graphic file with name nihms-1847152-t0050.jpg
Compound R4 R3 X IC50 (nM)a Reference
48 b SO2CH3 H CH2 4.8 [154]
49 b H graphic file with name nihms-1847152-t0051.jpg CH2 < 1 [154]
50 b H graphic file with name nihms-1847152-t0052.jpg CH2 < 1 [154]
51 b SO2CH3 graphic file with name nihms-1847152-t0053.jpg CH2 < 1 [154]
52 b SO2CH3 graphic file with name nihms-1847152-t0054.jpg CH2 < 1 [154]
53 b SO2CH3 graphic file with name nihms-1847152-t0055.jpg CH2 1 [155]
54 b SO2CH3 CH2CH2OH CH2 < 1 [155]
55 b CONH2 CH3 CH2 1.6 [152]
56 c H H NH 3.1 [156]
57 c H graphic file with name nihms-1847152-t0056.jpg NH 1.3 [156]
58 c H graphic file with name nihms-1847152-t0057.jpg NH < 1 [156]
59 c graphic file with name nihms-1847152-t0058.jpg CH3 NH < 1 [156]
60 c CONH2 CH3 N-CH3 < 1 [156]
61 c SO2CH3 CH3 NH < 1 [156]
a

The results are means of two independent experiments, each performed in duplicate (HNE enzyme assay).

b

The absolute configuration (S) has been unambiguously assigned by X-ray structure analysis.

c

The absolute configuration (R) has been unambiguously assigned by X-ray structure analysis.